Peritoneal macrophages from KODMAC-L or control-L before HFD and/or human
monocyte-derived macrophages from type 2 diabetics were cultured for 5 d in vitamin
D-deficient or 1,25(OH)2D3-supplemented conditions. (A) Western blot
of ER stress and cholesterol signaling proteins). (B) Western blot of SERCA2b and CaMKII
activation (representative of n=4 per group), (C) Cholesterol uptake after
DiI-oxLDL stimulation in murine macrophages with or without CaMKII inhibitor KN-93 for 6 h
(n=7 per group) (*P<0.001 by ANOVA vs. all others
without KN-93, **P<0.05 vs. same cells without KN-93).
(D) Western blot of activated CaMKII and JNK, PPARγ, CD36, and ER stress protein
CHOP in murine macrophages with or without KN-93 (representative of n=4 per
group). SERCA2b activity from (E) murine macrophages cultured in
1,25(OH)2D3-supplemented media (n=4 per group), (F) human
macrophages cultured in vitamin D-deficient or
1,25(OH)2D3-supplemented conditions (n=5 per group), and (G)
human macrophages cultured in 1,25(OH)2D3-supplemented conditions
and infected with Vdr-siRNA or control siRNA (n=5 per group)
(*P<0.05 vs. control-L or vitamin D-supplemented for all).
(H) SERCA2b expression in murine control-L macrophage lysates immunoprecipitated with VDR
antibody and (I) Immunofluorescent staining for VDR (green, left), SERCA2b (red, middle),
and co-localization (yellow, right) in murine control-L macrophages. Scale bar represents
10 μm. (J) Schematic depicting VDR-driven modulation of SERCA2b activity and
induction of foam cell formation. Data expressed as mean ± SEM. See also Figure S4.